Incidence and Predictors of Mortality among Neonates Admitted for Congenital Heart Disease in Public Comprehensives Specialized Hospitals, Amhara Region, Ethiopia 2023

Abatwoy Ayfokru; Sisay Shewasinad; Fuad Ahmed; Mitku Tefera; Genet Nigusie; Emawaysh Getaneh

doi:10.1101/2023.09.24.23296057

Abstract

Background Congenital heart disease is typically defined as a structural abnormality of the heart and great vessels present at birth. The incidence and mortality of congenital heart disease in neonates vary worldwide and it is the leading cause of birth defects, morbidity and mortality.

Objective to assess incidence and predictors of mortality among neonates admitted for congenital heart disease in public comprehensives specialized hospitals Amhara region, Ethiopia a Retrospective follow-up study 2023

Method Institution-based retrospective follow-up study was conducted among 583 neonates with congenital heart disease admitted to Amhara region public comprehensive specialized hospitals from January 1^st 2018 to December 30^th, 2022. The study subjects was selected using simple random sampling techniques. Data were entered into EPI data version 4.6, then exported to STATA version 16. The log-rank test and Kaplan Meier failure curve was used to estimate and compare the probability of death. First bivariable then multivariable regression was done. After computing a hazard ratio with a 95% confidence interval, variables with a p-value of 0.05 or lower was considered to be significant predictors of mortality

Results Out of 583 congenital heart disease neonate 9.9% were developed death. The incidence rate of mortality among congenital heart disease neonates was 11.9% per 1000 with 4844 person-days of observation (95% CI;-0.009-0.015). In this study were found to be Sepsis(AHR:2.24(95%CI:-1.184.23),Cyanoticcongenital heart disease(AHR:3.49(95%CI:1.93-6.28), Home delivery(AHR:1.9(95%,CI:1.06-3.6), had maternal history of Gestational diabetes multiuse (AHR: 1.94 (95% CI 1.04-3.61). Neonates having another congenital malformations. (AHR 2.49(1.33-4.67). neonates have been Airway resuscitation needed during delivery (AHR: 0.43(95%CI: 0.18-0.98). were found to be a significant predictors of Congenital heart disease neonatal mortality.

Conclusion and recommendation The incidence rate of neonatal mortality among congenital heart disease neonate was high as compared to findings of other studies. sepsis, cyanotic congenital heart disease, home delivery, maternal history of gestational diabetes malts, others congenital malformation and Airway resuscitations needed during delivery were significant predictors of mortality for neonates with congenital heart disease. Hence, giving special attention to patients with identified predictors should be better

Introduction

Congenital heart diseases (CHDs) are defined as a gross structural abnormality of heart or intrathoracic great vessels due to congenital anomalies. This can affect blood flows through the heart and the rest of the body.[1, 2] It is one of the most common congenital defects and accounts for nearly one-third of all major congenital anomalies[3].In 2016 The World Health Organization informed that 9,274,915 children died due to heart anomalies. Congenital heart disease can have genetic causes. But can also result after exposure to several risk factors (i.e., environmental factors, maternal health and age)

There are several common forms of CHDs. including Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD), Patent Ductus Arteriosus (PDA), Coarctation of Aorta (CoA), Tetralogy of Fallot (TOF), Transposition of Great Arteries (TGA), Pulmonary Stenosis (PS), and Aortic Stenosis (AS) are common types of CHDs,[4, 5]

Atrial and ventricular septal defects accounted for 51% of cases, with a rise in incidence over time[5]. About 30–40% of CHD patients show symptoms in the first year of life, although 60% of them can be diagnosed by the first month of life.[6]

Congenital heart disease is related to increased neonatal death[7, 8].Approximately one-third of the congenital heart disease occurred during the first week of gestational age[9]. The mortality rate from congenital heart disease is higher in preterm newborns with low birth weight and comorbidity, the main cause of death was cardiogenic shock[10]. The neonatal mortality was still high during the first 28 day of life with congenital heart disease which indicates that continuous monitoring and early intervention may be beneficial[11]. Prevention and screening are key measures for lowering mortality rate among neonates with congenital heart disease. However, this is a difficult task. because public health workforce, epidemiologists, and pediatric heart surgeons are under staffed, poor health care infrastructure, lack of awareness to congenital heart disease[12, 13].

Globally over the last 15 years around 1.35 million live births are diagnosed with CHD every year [5].Worldwide 90% of newborns with CHD received inadequate medical care [14]. In 2017 the incidence rate of CHD was 17.9/1000 worldwide with 19.1/1000 for males and 16.6/1000 for females[15, 16]. Thirty percent of neonates die from CHD in the first month after birth[17]. According to the 2019 WHO report 217,000 neonates died due to CHD [18].Nine-tenths of the world’s babies born with CHD live in locations with little to no care where mortality remains high[3]. Every year an estimated 500,000 neonates in Africa born with CHD and need special treatment from a cardiology specialist. Congenital heart disease is a severe non-communicable disease that has a significant impact in low-and middle-income countries, the burden of congenital heart disease is vast, this major non communicable disease is largely hidden[19]

Asia, a population of 16 million people is served by one cardiac center[20]. There is one cardiac center for every 33 million individuals in Africa[21]. In Ethiopia one cardiac center served for 56 million people. Many of them died before receiving a diagnosis and the affected children’s families must travel significant distances for surgery and follow-up. CHD consequently has a negative impact on the daily activities and financial situation of family members that leading to decline in quality of life.in addition neonates with heart disease frequently have poor nutrition, infections, and pulmonary hypertension in low-income countries like Ethiopia which makes treatment more difficult. Overall providing care of these neonates is challenging since cardiac care requires a lot of resources, such as infrastructure, skilled personnel, and equipment.[22–25]. Congenital heart disease in neonates the second leading cause of death in the first year of life after infectious diseases[26].

Mortality in the first year of life was 12 times more likely in newborns born with severe forms of congenital heart disease[27],thus hundreds of neonates die each year from CHD, while millions more remain in desperate need of treatment in the developing countries[28] [29]. Neonatal mortality due to CHD is significantly underreported in sub-Saharan Africa[21, 23]. The targets for the Sustainable Development Goals and the Millennium Development Goals of reducing infant mortality are significantly affected by CHD [18].

Heart diseases require advanced diagnostic skills and delicate surgical procedures, which require a well-organized health system. Prior research shows that the Ethiopian health care system does not have enough medical personnel to diagnose CHD[30]. In addition to an inefficient health care system, the cost of preventing and treating heart diseases in Ethiopia poses a great burden on households[31]. Ethiopia About 66.7% of children with structural heart disease develop heart failure. It’s known that heart failure is a risk for neonatal mortality and the case fatality rate of HF was 13.9 %[32].

Estimating the scope of public health impact of congenital heart disease is significantly under estimated due to inadequate vital registration systems and inaccurate records of cause of death in developing countries. the recommendation of the International Society of Ultrasound and Gynecology to include the four-chamber view and visualization of the outflow tract views in the routine prenatal ultrasound assessment of the fetal heart is supported by evidence and has improved the rate of prenatal CHD detection and decreased mortality rates[33]. Preconception care decrease burden of occurrence of congenital malformation and malformation related mortality[34].

Similarly as far as the investigator searches there is limited evidence on the incidence and predicators of mortality among neonates with congenital heart disease in Ethiopia. Thus, this study investigated the incidence and predicator of mortality among neonates with congenital heart disease admitted to public comprehensives specialized Hospitals. Amhara region Ethiopia 2023. Therefore, the objective of this study was to assess incidence and predictors of mortality among neonates with congenital heart disease in public comprehensives specialized hospitals, amhara region, in Ethiopia (show fig 1).

Figure 1 Schematic presentation of conceptual framework of incidence and predictors of mortality among neonates admitted for congenital heart disease in public comprehensives specialized hospitals, amhara region in Ethiopia 2023

Method

Study area and period

The study was conducted from April 01 to 15/08 /2015, at selected governmental Comprehensive Specialized Hospitals in the Amhara regional state in Ethiopia. The capital city of Amhara region is Bahir Dar which is the seat of the Regional Health bureau (ARHB) of Amhara,

According to 2020 the Health and Health Related Indicators published by MoH. Amhara has 82 Hospitals, 861 Health Centers and 3,565 Health Posts. Among those 82 hospitals in the region, the University of Gondar, Dessie, Felege-Hiwot, Tibebe-Ghion, Debre Markos, Woldia, Debre Tabor, and Debre Berhan are Comprehensive Specialized Hospitals.

Study design

Institutional based retrospective follow-up study was conducted

Source population

All neonate with congenital heart disease and admitted to the NICU wards of Amhara regional state Comprehensive Specialized Hospitals, From January 1^st 2018 to December 30^th 2022, were the source population.

Study population

Selected neonates with congenital heart disease were admitted to the NICU wards of Amhara regional state’s Selected Comprehensive Specialized Hospitals, from January 1^st 2018 to December 30^th 2022.

Eligibility criteria

Inclusion criteria

All newly diagnosed and admitted neonates with congenital heart disease from January 1^st 2018 to December 30^th 2022.

Exclusion criteria

Congenital heart disease neonates with incomplete records (not registered date of admission, date discharge, neonatal status, and neonatal age), and unknown outcome status were excluded the study.

Sample size determination

For the first specific objectives sample size was determined by using single population proportion formula by considering the following assumptions. Prevalence (p) of 35.8% taken from a study in Addis Ababa referral public hospitals[35] 95% confidence level, 5% margin of error and 10% of incomplete records.

Where; p was the proportion of prevalence and associated factor of congenital heart disease among congenital anomalies (0.358%) d=5% or 0.05 because the confidence interval is 95%

Sampling technique and Sampling procedure

For comprehensive specialized hospitals were selected randomly by lottery method. Number of participants to each Hospital was allocated by proportion to population size. The sampling interval of each hospital were calculated by dividing the number of eligible study participants for allocated sample size of that Hospital, finally the first participants were selected by using systematic random sampling technique every K^th (7176/583=12) intervals. The first participants were selected by lottery method from 1-12 and the number 6 was selected. Then, the next selection was continued every 12^th intervals until obtained the required sample size was achieved (Show fig 2).

Figure 2 Schematic presentation of sampling procedure on incidences and predictor of mortality among neonates with congenital heart disease at Amhara region public Comprehensive Specialized Hospitals, Ethiopia, 2023.

Study variables Dependent Variables

Incidence of neonatal mortality with CHD

Independent variables

Socio-demographic factors: Maternal age, marital status, Residency

Maternal behavioral factors: Maternal habit of alcohol intake, smoking, chat chewing,

Maternal medical factors: History of maternal DM. pregnancy induced hypertension, HIV, cardiac problems, TB, anemia, Syphilis, Family history of CHD

Maternal obstetrical factors: ANC visits. History of folic acid intake, Place of delivery, Mode of delivery, history of Abortion, Type of birth, gravidity, parity. Preterm delivery, RH factors, prolonged delivery

Neonatal factors: Age of neonates, sex of neonates, Birth weight. Apgar score status, Gestational age, date of admission and date of discharge, types of intervention,, comorbidities, length of hospital stay, types of CHD, child status and other congenital anomalies

Data collection tool and procedure

A pretested pre-structured checklist were collect data from the NICU registration book. The checklist for data extraction tool consists of socio demographic related variables, maternal behavioral and medical related variables, obstetric and neonatal related variables, Time from the admission of CHD was the starting point for retrospective follow-up and the endpoint was the date of discharge. The recordings of all study participants were selected according to the eligibility criteria. The questionnaire was adapted and modified from reviewing different literature and guidelines[10, 29, 35–41], The questionnaire was prepared as a checklist in the English language, The reliability of the tool were assessed by conducting a pretest study and face and content validity was ensured, to ensure its eligible and to avoid any confusion regarding the understanding of the questionnaire and the questionnaire was(occupational status, educational status, History of taking of medication during pregnancy, History of mal-presentation, heart auscultation status, types of CHD, time of diagnosis to CHD) modified based on feedback from the study, Health professionals who have been working in the treatment center were collected the data. Prior to data collection period, one day of training was given for the data collectors and supervisors on the objectives of the study, data collection method and tools and how to maintain the confidentiality of the data. During data collection time, Supervisors and data collectors was daily discussed, on faced problems during data collection time until the data collection was accomplished.

Operational definitions

Neonate: The first 28 days of life[42]

Censored; refers to neonates with congenital heart disease were improved, discharged, or against medical treatment, refers to others center and outcome known after 28 days

Event; - The event was death of neonates with congenital heart disease while in the hospital and whose death report was recorded with in 28days.

Time to event; - A time from the admission date by CHD to the discharge date while the neonate is event. It will measured by subtracting the date of admission from the date of discharge

Co-morbidities; Newborns with CHD and have other illnesses such as sepsis and under nutrition [43]

Incomplete charts: when one of the independent variables was not registered (date of admission and discharge, discharge status, and neonatal age)

Medical disorders in the mother: - Any registered medical diagnosis history of the mother on the maternal and neonate’s medical record[44]

Antenatal care visit: - Any history of follow up care provided by skilled health-care professionals for both mother and baby during pregnancy designated or recorded on chart[44]

Low APGAR SCORE: - A neonate who have an Apgar score of <7[45]

Preterm (premature) birth: - Neonate born before 37 weeks of gestational age[45]

Low birth weight: - neonates who have <2500 gram of birth weight[46]

Congenital heart defect; -major or minor congenital anomalies defined as anatomical structural and functional defect present at birth which was confirmed by pediatricians or echocardiography [47]

Data quality control assurance plan

The checklist was pre-tested among 5% of the study participants in other than the study area (Dessie Referral Hospital) to assure the data quality. The necessary modifications and corrections were made to standardize and ensure its validity. Experts in the clinical and academic area were involved to evaluate the content of the questionnaire. The tool utilized in the current study was validated and found to be reliable. The data collectors and supervisor were senior experienced BSc nurses who are working in NICU (one supervisor and two data collectors were select each hospital). One day of training was given on the purpose of the study, the data collection tool (checklist), data collection methods, and ethical concerns during data collection. The supervisor was monitored the data collection process. The principal investigator and supervisor have done spot-checking and reviewing the complete checklist by the data collectors to ensure the completeness and consistency of the collected information (data). Consistency was examined through a random selection of cards by the principal investigator, during the data collection time, close supervision and monitoring were carried out by the supervisors and data entry were also done using Epi Data software.

Data Processing and Analysis

After checking data completeness and consistency, the collected data was coded and entered into Epi- data version 4.6 then exported into STATA version 16 for cleaning and analysis. Data were summarized with text, table, figure, mean, and SD based on the data nature. The frequency distribution was used for categorical data and results were presented as graphs & tables. During the analysis, the outcome was used as a dependent variable indicating death as an event of interest. The outcome of each participant was dichotomized into death (event of interest), coded as “1”, and censored coded as “0”. A variance inflation factor (VIF 1.06) to assess multi-collinearity between independent variables). Was done. “Kaplan-Meier survival estimates” was used to estimate the mean survival time, cumulative probability of survival and survival differences between covariates were done. A log-rank test was used to assess statistically differences across groups of independent variables. The proportionality assumptions were tested using a Schoenfeld residual global test (p value 0.6337).a Cox-Snell residual test was used to evaluate the model’s goodness of fit. in order to identify predictors of mortalities, A bivariable and multivariable Weibull regression models was used. Variables with a P-value of less than 0.25 in the bivariate analysis was entered into the multivariate analysis. In multivariable analysis, a variable with a p-value less than 0.05 at a 95% confidence level was considered as an independent predictor of mortality in CHD neonates.

Ethical consideration

The IRB board of Debre Berhan University’s Asrat Woldeys Health Science Campus granted ethical clearance (protocol number= IRB 123). For data collection, the University submitted a formal letter of cooperation to the selected public hospital administrative body. Permission was obtained from all relevant bodies at the chosen hospital. The data collectors were also in charge of searching for and obtaining the medical records of the chosen samples. The confidentiality of patients’ records was maintained by omitting their names and personal identification from the data collection format.

Results

Socio-demographic characteristics of mother of neonate

A total of 583 neonates with CHD medical charts were reviewed, of which 566 were complete the remaining 11 were incomplete, and 6 weren’t available at the time of data collection. However, these charts were replaced with other charts by randomly selecting charts that hadn’t been chosen earlier. In this study from the total study participants 525 (90.5%) were censored and 58 (9.95%) were events (death), the mean age of participants was 32.80 (SD ± 0.30) years (95% CI 32.20--33.40) Over half of the mothers, 310 (53.17%) were older than 35 years. Nearly 506 neonatal mothers (86.79%) were married. About 69.3 % of the neonates had age greater than seven days. Three hundred ninety three participants (67.41%) were females. More than three fourth of participants 487 (83.53%) were rural residence (Table 1).

View this table:

Table1: Socio demographic characteristics predictor’s of neonatal mortality with congenital heart disease admitted in NICU ward of public comprehensives specialized hospitals Amhara region, Ethiopia 2023 retrospective follow up study from Jannuary1, 2018-December 30, 2022

Maternal behavioral factors

Among 583 neonatal mothers participated in this study, 106 (18.18%) of them drank alcohol, 135 (23.16%) smoked cigarettes, and 118 (20.24%) chewed khat during this pregnancy (Table 2).

View this table:

Table 2: Maternal behavioral factors characteristics of predictor’s of neonatal mortality with congenital heart disease admitted in NICU ward of public comprehensives specialized hospitals Amhara region, Ethiopia 2023 retrospective follow up study from Jannuary1, 2018-December 30, 2022.

Maternal Medical Factors

Of the total neonatal mothers included in this study, 72 (13.35%) had gestational diabetes mellitus, 40 (6.66%) had cardiac problems, 57 (9.78%) had HIV/AIDS, 37 (6.35%) had syphilis, and 129 (22.13%) had a history of congenital heart disease (CHD), 22 (3.77%) of mothers had a history of TB, and 17 (2.92%) of mothers had a history of hypertension (Table 3).

View this table:

Table 3: Maternal medical characteristics of predictor’s of neonatal mortality with congenital heart disease admitted in NICU ward of public comprehensives specialized hospitals Amhara region, Ethiopia 2023 retrospective follow up study from Jannuary1, 2018-December 30, 2022.

Maternal obstetrical factors

The majority of neonatal mothers, 506 (86.79%) had two or more pregnancies, and 452 (77.53%) had spontaneous vaginal births and 301 (51.63%) had ANC follow-up (Table 4)

View this table:

Table 4 Maternal obstetrical factors characteristics of predictor’s of neonatal mortality with congenital heart disease admitted in NICU ward of public comprehensives specialized hospitals Amhara region, Ethiopia 2023 retrospective follow up study from Jannuary1, 2018-December 30, 2022.

Neonatal related characteristics

Among newborns with CHD who were admitted to the NICU, 389 (66.72%) had low birth weight, 260 (44.60%) had neonatal sepsis, 172 (29.50%) had PNA, 320 (54.89%) had preterm delivery, and 49 (8.10%) had an additional cardiac abnormality. At admission, the mean neonatal birth weight was 2253 grams (Table 5).

View this table:

Table 5: Neonatal medical & other characteristics of CHD neonates admitted to NICU at Amhara region public comprehensives specialized hospitals from Jannuary1, 2018-December 30, 2022.

The incidence rate of mortality among congenital heart disease neonates

A total of 583 CHD neonates that were admitted to NICU had been followed from 1 to 28 days. The Overall mean hospital stay was 8.64 (95%CI: 8.17-9.12) with a minimum and maximum follow-up time of 1 and 28 days and the total person-time at risk was 4844 person day observations, In this finding, 58(9.79%) of the study participant were events (death) from 583 CHD neonates, 525 (90.05%) were censored (recovered, left NICU against medical advice, outcome after 28 days and referred to other center) at the end of the follow-up (Figure 3).

Figure 3 Outcome of neonates admitted to NICU of Amhara region comprehensives specialized hospitals in Ethiopia, January 1st, 2018 – December 31th, 2022.

The overall incidence rate of mortality among congenital heart disease neonates was 11.9 (95% CI;-0.009-0.015) per 1000 person days observation. In this study, the mortality rate among male and female congenital heart disease neonates was 13.1 and 11.3 per 1000 person day observations respectively. The rates of mortality among urban and rural residents were 21.3 and 9.8 per 1000 person day observations respectively

Early neonates (<7 days) had a higher rate of mortality 22.0 (95%% CI-0.015-0.031) as compared Late neonates ones (>=8 days) 7.4(95%;-CI.005-0.011) per 1000 person day observations. The mortality rate of congenital heart disease neonates varied across different categories of clinical characteristics of neonates. The incidence of mortality among patients presented with and without comorbidity was 16.5 and 7.2 per 1000 person day observations respectively. In addition, patients who had neonatal sepsis at admission revealed a higher incidence of mortality rate (21.0) than their counterparts (5.3) and sever acute malnutrition (23.0) without sever acute malnutrition (8.7) respectively.

The incidence rate of mortality of cyanotic CHD neonates (37.3) and Asyanotic CHD (6.3) and history of HIV/AIDS (41.4) without HIV/AIDS (8.7) per 1000 person day observations respectively.

This shows that neonates with maternal history of HIV/AIDS, cyanotic CHD, and sever acute malnutrition having the highest incidence of neonatal mortality with congenital heart disease than the above predictor variable

Overall survival of congenital heart disease neonates admitted to NICU

The overall Kaplan-Meier estimate showed that the probability of survival of CHD neonates was high on the 1st day of admission, which comparatively decreases as follow-up time increases (fig 4).

Figure 4 Overall Kaplan-Meir survival estimate of CHD neonates admitted to NICU at Amhara region comprehensives specialized public Hospitals in Ethiopia Jannuary1, 2018-December 30, 2022.

During the 1st day of hospital stay, a maximum 99.6% (95%CI: 98, 99.9) probability of survival was observed with a SD± of 0.0025. The overall mean survival time of neonates admitted to NICU in the study was 8 days with 90.3% (95% CI 0.86-0.93) a SD± 0.015. This study also showed that the probability of neonatal survival at the 7th and 14th day of hospital stay was 92.5% (95% CI 89 94) SD± = 0.013) and 82.1 % (95% CI: 76--86) SD± = 0.025), respectively. At the 20 days of hospital stay, the overall survival probability of neonates was 74.1% (95% CI: 65-80) with a standard error of 0.039 (Table 6).

View this table:

Table 6. A life table showing survival probability of CHD Neonates was admitted to NICU selected public hospitals Amhara Region, Ethiopia, January 1st, 2018-December 30th, 2022.

Survival function among predictor variables

In this study, CHD Neonates with comorbidity had a lower survival time of 15 days (95% CI 73-85 :) of mean survival time compared to those who had not been diagnosed with comorbidity. At the 28 days of hospital stay, the overall survival of neonates with comorbidity and without comorbidity was 80 % and 92 %, respectively (Figure 5). This survival time difference was statistically significant with a Log-rank test (x²) p-value = 0.0021.

Figure 5 Kaplan-Meir survival estimate among CHD neonates admitted to NICU at public hospitals in Amhara Region with the category of comorbidity and without comorbidity from January 1, 2018-December 30^th, 2022

In this study, CHD Neonates with Cyanotic CHD had a lower survival time of 19 days (95% CI-67-81) of mean survival time compared to those who had been diagnosed with Asyanotic CHD. At the 28 days of hospital stay, the overall survival of neonates with Cyanotic CHD and Asyanotic CHD was 75.4% and 83%, respectively (Figure 6).

Figure 6 Kaplan-Meir survival estimate among CHD neonates admitted to NICU at public hospitals in Amhara Region with the category of Cyanotic and Asyanotic congenital heart disease from January 1, 20118-December 30, 2022.

As shown from the figure plotted below, the Kaplan Maier survival function for CHD neonates from mothers who have HIV positive was, a lower survival time (median survival time of 18 days, 95% than those Who have no HIV (no median survival time with overall survival probability of 77% and 83% % at the end of the study period respectively. The difference was statistically significant at a p-value = 0.000 (Show figure 7).

Figure 7 Kaplan-Meir survival estimate among CHD neonates admitted to NICU at public hospitals in Amhara Region with the category of Maternal HIV and without from January 1, 2018-December 30, 2022.

Factor associated with Incidence of neonatal mortality with Admitted to Congenital heart disease

Cox proportional hazard regression model was used to analyze the relationship between variables and their effect on the recovery time. Bivariate analysis was performed using cox proportional hazard regression to identify which variable had an association with incidence of neonatal mortality to congenital heart disease. Variables like gestational diabetic multiuse (GDM), home delivery, others congenital malformation, sepsis, Airway resuscitation needed during delivery, cyanotic congenital heart disease, were statistically significant with a p-value of 0.25 or less than are predictors of neonatal mortality with congenital heart disease. Therefore, all covariant which had an association with the outcome variable with a p-value of 0.25 or less were entered into the multivariate model.

Multiple cox regressions model was performed for those identified as independent factors in bivariate analysis. Therefore, variables like gestational diabetic multiuse (GDM), home delivery, others congenital malformation, sepsis, Air way resuscitation needed during delivery, and cyanotic congenital heart disease were found to be statistically significant predictors with a p-value of 0.05.

In multivariate analysis, the result shows that the neonates with congenital heart disease who also had neonatal sepsis died 2.24 (AHR: 2.24 (95% CI;-1.18-4.23) times more frequently than those with congenital heart disease who did not have neonatal sepsis (AHR: 2.24 (95% CI;-1.18-4.23), Neonates with cyanotic congenital heart disease had a(AHR 3.49 (95% CI: 1.93-6.28) times higher mortality rate than those with a cyanotic congenital heart disease. Neonates with congenital heart disease were 1.9 times more likely to die at home delivery than those who were delivered in health institution (AHR: 1.9 (95% CI: 1.06-3.6))

The death rate for CHD neonates with a history of maternal GDM had (AHR 1.94(95%CI 1.04-3.61) time’s higher mortality rate than those with congenital heart disease who did not have maternal History of GDM (AHR 1.94 (95% CI 1.04-3.61).Neonates having another congenital malformations. (AHR 2.49(1.33-4.67) times increased the risk of neonatal death compared to not having another one. (AHR 2.49(1.33-4.67). The risk of death among CHD neonates who required airway resuscitation during delivery increased by 57% compared to those who did have (AHR: 0.43 (95%;-0.18-0.98)) (show table 7).

View this table:

Table 7: Bivariate & multivariate Cox proportional hazard regression outputs of Congenital Heart disease neonates admitted to NICU at Amhara Region public comprehensives specialized hospitals from Jannuary1, 2018-December 30/2022 in Ethiopia.

Test of proportional hazard assumption by Schoenfeld’s residuals

Testing the proportional hazard assumption is vital for the interpretation and use of fitted proportional hazard models. Therefore, in this study goodness-of-fit (GOF) particularly the Schoenfeld residuals proportional hazard assumption test for the individual covariates and the global test was used. If P-Value < 0.05, then the proportional hazard assumption is violated. Each covariate (P-Value > 0.05) and all of the covariates simultaneously (Global test for Cox proportional hazard P-Value=0.6337> 0.05) met the proportional hazard assumption (Show table 8).

View this table:

Table 8: Schoenfeld Residuals test for Cox-Proportional Hazard Regression model assumption (estat, phtest) of each variable for neonates admitted in Amhara Region comprehensives specialized Hospitals in Ethiopia, January 1st, 2018 – December 31th, 2022.

Cox-Snell residuals Test

Cox-Snell residuals test is used to assess the overall goodness of fit in survival models. It is done graphically with the usual graphs of Cox-Snell, and it is observed that residuals from a correctly fitted model follow exponential unite distribution along the 45 degree of slope (baseline). It is used to identify extreme observations that need additional investigation. In this study, the hazard function follows the 45-degrees line closed to the baseline. It showed that the multivariate cox regression model is fitted for the analysis and interpretation of the results of this study (fig.8)

Figure 8:

Cox-Snell residual cumulative hazard graph on neonates admitted in NICU with congenital heart disease Amhara Region at Comprehensives Specialized Hospitals in Ethiopia, January 1st, 2018 December 31th, 2022 in Ethiopia.

Discussion

Incidence of mortality among neonates with congenital heart disease was 11.9 (95% CI; - 0.009-0.015) per 1000 persons of observation which was in line with a study conducted, USA neonatal mortality (0.37/1000%)[48], in gingdao china (9.38/1000%),[49],south china was approximately 11.1 per 1,000 live births [50] and Sri lanka 1.56/1000 live birth[51], The possible reason could be due to the study were conducted at the hospital level, in which different complicated neonatal cases can be referred from different corners of the region, so due to a high number of complicated cases the mortality could be increased.

However, it was higher than the study conducted in Europe (0.7%/1000) [52] & Spain (4.58/1000). [53], This variation might be due to the NICU physical environment difference. For example, in developed countries, there is a dedicated ward space and enough neonatal beds even though the distance between NICU and the labor ward is closely constructed. The other possible reason might be the ward of those developed nations might be staffed with health workers with specialty training and skills like neonatologists, pediatric surgeon & nursing specialties than sub saran Africa including Ethiopia. Another possible explanation might be also a difference in the health care utilization of mothers due to discrepancies in sociocultural factors.

On the contrary finding lower than the study conduct in Sweden northern European country 17/1000(95% CI, 16.8–18.6)[11] and brazil/ (85%/1, 0000), births[54]this might be due to differences in length of follow-up time, study period, study area, and study design

A multivariate analysis found that neonates with congenital heart disease who also had neonatal sepsis died 2.24 (AHR: 2.24 (95% CI;-1.18-4.23) times more frequently than those with congenital heart disease who did not have neonatal sepsis (AHR: 2.24 (95% CI;-1.18-4.23), This was in line with a study conducted in, TASH, Addis Ababa, Ethiopia, were 4.4 times more likely to dies [AHR=4.418 (95%CI: 1.617-12.072)].[55] Northern and south western Ethiopia [35, 55–57]and united states of America.[58].this discrepancy may be study area, Congenital heart disease neonates have decreased immune function because of the low level of some immune cells such as immunoglobulin G resulting from the low transfer of maternal immunoglobulin G and predispose to varies health problems like malnutrition, developmental delays and infection and neonates with CHD with increased pulmonary blood flow thus presents with pneumonia and congestive cardiac failure (CCF) amongst other features, neonates with congenital heart diseases are more vulnerable to infections following the fact that they had an anatomical defect that causes hemodynamic disturbance of lung circulation and mucosal edema finally leads to decreased lung compliance and develop infections. So preventing neonatal sepsis for neonate with congenital heart disease is important to decrease neonatal mortality and helps to implement SDG

Neonates with cyanotic congenital heart disease had a 3.49 (95% CI: 1.93-6.28) times higher mortality rate than those with asyanotic congenital heart disease. This result was consistent with a study done in Atlanta, Georgia (69) Spain (59), this difference may be due to differences in model analysis, neonates are at risk of having serious complications within the first few days or weeks of life, often require emergency care and is silent in fetal life B/C right-to-left shunting across the foramen ovals and ductus arteriosus. in the presence of pulmonary outflow tract obstruction or persistent pulmonary hypertension of the newborn. Which could increase the risk of dying than Acyanotic congenital heart disease

Neonates with congenital heart disease were 1.9 times more likely to die at home delivery than those who were delivered in health institution (AHR: 1.9 (95% CI: 1.06-3.6)).This finding was supported by studies in Iran, Sub-suharan Africa(56),Ethiopia[30], in Ethiopia due to financial problems, lack of knowledge, preference of traditional medicines for a sick neonates, poor roads. Poor health facility readiness, the poor economy of families, lack of ambulance, cultural and traditional beliefs, and unprofessional behaviors which were the major barriers hindering the uptake of delivery of health care facility. This finding indicates that programs and policies should focus on the strengthening of the quality of care in maternal and child health.so improving the quality of care could be important to avoid the negative attitude of mothers towards the services provided by health institutions,

The death rate for CHD neonates with a history of maternal GDM had (AHR 1.94(95%CI 1.04-3.61) time’s higher mortality rate than those with congenital heart disease who did not have maternal History of GDM (AHR 1.94 (95% CI 1.04-3.61). This study finding is consistent with the study conducted at in Ethiopia Addis Ababa hospitals (47). This might be GDM related to the complications Protected due to diabetes mellitus during pregnancy because diabetes mellitus can result in hypoglycemia, hypocalcaemia, respiratory distress, growth restriction, polycythemia, increased magnesium amount, respiratory distress, congenital anomalies, and excessively increased amount of bilirubin

According to this study. Neonates having another congenital malformations. (AHR 2.49(1.33-4.67) times increased the risk of neonatal death compared to not having another one.(AHR 2.49(1.33-4.67).This finding is supported by studies done by TASH Addis Ababa Ethiopia ([AHR=2.416 (95%CI: 1.367-4.264)] (76) and higher the study conduct in Finland (7 to 50% of the neonates with congenital heart disease with other congenital malformation a greater risk of comorbidity and mortality [59] This discrepancy might be due to difference in methodology, lifestyle, economic status, access to health care facilities, and level of education of the general public. may have contributed to increased incidence of risk of mortality to CHD in Ethiopia. Furthermore, poor access to health care facilities in our country, accompanies many patients to seek alternative treatments such as, using herbal remedies, prayers and rituals that encountered a delay in care which further complicating the disease process,

The risk of death among CHD neonates who required airway resuscitation during delivery increased by 57% compared to those who did have (AHR: 0.43 (95%;-0.18-0.98)),this finding is also higher the study conducted in Belgium is 36%[60] The possible reason for the observed discrepancy might be due to the difference in sample size, study setting, the severity of the disease, and the methodology of studies.

Transition from fetal to postnatal life is a complex process. Even in the absence of congenital heart disease, about 4–10% of newborns require some form of assistance in the delivery room. Neonates with complex congenital heart disease should be expected to require significant intervention and thus the resuscitation team must be well prepared for such a delivery.

Conclusion

The rate of mortality among hospitalized congenital heart disease neonates in this study was high as compared to findings of other studies, in this study the overall incidence of congenital heart disease neonatal mortality was 11.9/ per 1000 day observation, congenital heart disease neonates from sepsis, Home delivery, maternal history of GDM, other congenital malformation, Asyanotic CHD and neonatal resuscitation need careful observation and early intervention of cases is crucial to prevent the potential CHD related mortality, Furthermore, strengthening the health care delivery system to satisfy the need of the patients should get due attention to reduce the incidence of mortality from CHD cases

Strength and Limitations

Strength

The study area covers Amara region Referral Hospital. As a result, its generalizability to all hospitals of Amhara region in may be possible. This study was conducted by using five consecutive years of admission and Study participants were included from different healthcare institutions, which result in to increase in its representatives.

Limitations

Some critical covariates obtain from the mother were missing. These might be significant predictors of neonatal mortality such educational status, occupational status, nutritional status, economic status and did not include biomedical profiles and medication-related variables which could be potential predictors of congenital heart disease neonatal mortality.in addition to the study was retrospective cohort study design

Recommendations

Even though quality of health care service expanded, especially for maternal and newborn care, neonatal mortality is still a concerning issue in all Ethiopia’s study areas. Based on the findings of this study, I forwarded the following recommendations.

Policy Makers and Local leaders

As already known, currently, there is only one surgical treatment center for neonates with congenital heart disease at TASH. FOMH should expand the surgical treatment centers other than TASH because almost all cases of congenital heart disease were referral cases and the majority were died due to delay in surgical intervention and delaying reaching care. FMOH should also incorporate the standard of care for neonates diagnosed with congenital heart disease in the national guidelines. The accessibility advanced care center and quality of surgical interventions also need emphasis to reduce incidence of mortality neonates with heart disease. Collaborative and advanced care should be considered for neonates with congenital heart disease.

Amhara Regional Health Bureau

Amhara regional health bureau had better strengthen the treatment strategies of neonates diagnosed with congenital heart disease by supplying the equipment needed for intervention like mechanical ventilation, Suction machine Echocardiography and isolated Operation room for timely surgical intervention and should make availability of total parenteral nutrition in the hospitals

Health Professionals and Health Institutions

To increase health facility delivery, health care providers and health care facilities strengthening raising women’s awareness on the benefits of delivering in health facility, male involvement in the use of maternal health services, increasing women decision-making power, addressing common barriers of lack of transport, and compensations for transport expenses to alleviate the cost of transport and health education focusing on the potential threats of delivering at home at recommended in the health care providers

Health care provider had screened and tasted for GDM typically between 24-28 weeks of gestation and increase awareness of balanced diet

All health care providers had insures that all babies receive essential newborn care (ENC), including appropriate cord care, early initiation and exclusive breastfeeding, maintenance of warmth, and prompt treatment with antibiotics and who are working in labor and delivery ward should be give attention for mothers those have antenatal, intrapartum fever and refer the neonates to NICU for early initiation of management

Pregnant mothers should attend regular ANC follow-up and early diagnosis of congenital heart disease is vital to improve the quality of care provided for newborns

To future researchers

Upcoming researchers shall conduct a longitudinal prospective cohort study to incorporate impossible variables in retrospective study like maternal socio-economic, genetic, biomedical profiles and medication-related variables and environmental factors and a qualitative study should be conducted to explore the possible psychosocial support for mothers who lost their babies due to congenital heart disease.

Supporting information

S1 IRB letter

S2 Plos one studies clinical checklist

S3 STROBE-statement checklist

Authors’ contributions

Conceptualization: Abatwoy Ayfokru.

Data curation: Abatwoy Ayfokru.

Formal analysis: Abatwoy Ayfokru.

Investigation: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie

Methodology: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Project administration: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Resources: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Software: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Supervision: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Validation: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Visualization: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Writing – original draft: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Writing – review & editing: Abatwoy Ayfokru, Sisay Shewasinad, Fuad Ahmed, Mitiku Tefera,Emawaysh Getaneh and Genet Nigusie.

Acronyms and abbreviation

ANC: Antenatal Care
AHR: Adjusted Hazard Ratios
ARHB: Amhara Regional Health Bureau
CHD: Congenital Heart Disease
CHR: Crude hazard ratio
CI: Confidence interval
CPH: Cox proportional Hazard Regression
GDM: Gestational Diabetes Mellitus
LIMIC: Low Income and Middle Income Countries
MOH: Ministry of Health
NICU: Neonatal intensive care units
SD: Standard deviation
TASH: Tikur Anbesa specialized Hospital
TOF: Tetralogy of Fallot
USA: United States of America

Acknowledgments

First, we want to express our heartfelt gratitude to Debre Berhan University Asrat Woldeyes Health Science Campus School of Nursing & Midwifery for giving valuable support. Secondly, the deepest gratitude to all Pre-Publication Support Service (PRESS) of PLOS ONE, the staff member of amhara region comprehensives specialized hospitals, study participants and the data collectors their cooperation in this study.

Reference

1.↵
Liu, Y., et al., Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. International journal of epidemiology, 2019. 48(2): p. 455–463.
OpenUrl CrossRef PubMed Google Scholar
2.↵
Yu, Z., et al., Congenital heart disease in a Chinese hospital: pre-and postnatal detection, incidence, clinical characteristics and outcomes. Pediatrics International, 2011. 53(6): p. 1059–1065.
OpenUrl CrossRef PubMed Google Scholar
3.↵
Zikarg, Y.T., C.T. Yirdaw, and T.G. Aragie, Prevalence of congenital septal defects among congenital heart defect patients in East Africa: A systematic review and meta-analysis. Plos one, 2021. 16(4): p. e0250006.
OpenUrl Google Scholar
4.↵
Hurisa, T., H. Megersa, and T. Tsegaye, Delayed in Diagnosis of Congenital Heart Disease and Associated Factors Among Pediatric Patients in Cardiac Center Addis Ababa, Ethiopia, 2021/2022 GC. American Journal of Health Research, 2022. 10(3): p. 51-62.
Google Scholar
5.↵
Van Der Linde, D., et al., Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. Journal of the American College of Cardiology, 2011. 58(21): p. 2241–2247.
OpenUrl FREE Full Text Google Scholar
6.↵
Schulkey, C.E., et al., The maternal-age-associated risk of congenital heart disease is modifiable. Nature, 2015. 520(7546): p. 230-233.
Google Scholar
7.↵
MacColl, C.E., et al., Factors associated with in utero demise of fetuses that have underlying cardiac pathologies. Pediatric cardiology, 2014. 35: p. 1403–1414.
OpenUrl Google Scholar
8.↵
Leite, D.d.L., H. Miziara, and M. Veloso, Congenital cardiac malformations in pediatric necropsies: characteristics, associations and prevalence. Arquivos Brasileiros de Cardiologia, 2010. 94: p. 294–299.
OpenUrl Google Scholar
9.↵
Torres-Cosme, J.L., et al., Mortality from congenital heart disease in Mexico: a problem on the rise. PLoS One, 2016. 11(3): p. e0150422.
OpenUrl Google Scholar
10.↵
Lopes, S.A.V.d.A., et al., Mortality for critical congenital heart diseases and associated risk factors in newborns. A cohort study. Arquivos brasileiros de cardiologia, 2018. 111: p. 666–673.
OpenUrl Google Scholar
11.↵
Mandalenakis, Z., et al., Survival in children with congenital heart disease: have we reached a peak at 97%? Journal of the American Heart Association, 2020. 9(22): p. e017704.
OpenUrl PubMed Google Scholar
12.↵
Cucu, I. and M. Chifiriuc, Congenital heart disease: global burden and challenges to eliminate health disparities. Ann Public Health Reports, 2018. 2(1): p. 26–9.
OpenUrl Google Scholar
13.↵
Musa, N.L., et al., The global burden of paediatric heart disease. Cardiology in the Young, 2017. 27(S6): p. S3–S8.
OpenUrl PubMed Google Scholar
14.↵
Saxena, A., Status of pediatric cardiac care in developing countries. Children, 2019. 6(2): p. 34.
OpenUrl Google Scholar
15.↵
Rashid, U., et al., Pattern of congenital heart disease in a developing country tertiary care center: Factors associated with delayed diagnosis. Annals of pediatric cardiology, 2016. 9(3): p. 210.
OpenUrl Google Scholar
16.↵
Wu, W., J. He, and X. Shao, Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017. Medicine, 2020. 99(23).
Google Scholar
17.↵
Glidewell, J., et al., Actions in support of newborn screening for critical congenital heart disease—United States, 2011–2018. Morbidity and Mortality Weekly Report, 2019. 68(5): p. 107.
Google Scholar
18.↵
Su, Z., et al., Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study. EClinicalMedicine, 2022. 43: p. 101249.
Google Scholar
19.↵
Hewitson, J. and P. Zilla, Children’s heart disease in sub-Saharan Africa: challenging the burden of disease: children’s heart disease. Sa Heart, 2010. 7(1): p. 18–29.
OpenUrl Google Scholar
20.↵
Vervoort, D., et al., Global cardiac surgery: access to cardiac surgical care around the world. The Journal of thoracic and cardiovascular surgery, 2020. 159(3): p. 987–996. e6.
OpenUrl PubMed Google Scholar
21.↵
Hoffman, J.I., The global burden of congenital heart disease. Cardiovascular journal of Africa, 2013. 24(4): p. 141–145.
OpenUrl Google Scholar
22.↵
Zimmerman, M.S., et al., Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Child & Adolescent Health, 2020. 4(3): p. 185-200.
Google Scholar
23.↵
Jivanji, S.G., et al., Congenital heart disease in East Africa. Frontiers in pediatrics, 2019. 7: p. 250.
OpenUrl Google Scholar
24.
Howell, H.B., et al., Neurodevelopmental outcomes of children with congenital heart disease: A review. Current Problems in Pediatric and Adolescent Health Care, 2019. 49(10): p. 100685.
OpenUrl CrossRef Google Scholar
25.↵
Zilla, P., et al., Global unmet needs in cardiac surgery. Global heart, 2018. 13(4): p. 293–303.
OpenUrl Google Scholar
26.↵
UNICEF, Estimates generated by the UN Inter-agency Group for Child Mortality Estimation (UN IGME). 2014.
Google Scholar
27.↵
Otaigbe, B. and P. Tabansi, Congenital heart disease in the Niger Delta region of Nigeria: a four-year prospective echocardiographic analysis: cardiovascular topic. Cardiovascular journal of Africa, 2014. 25(6): p. 265–268.
OpenUrl Google Scholar
28.↵
Massoure, P.-L., et al., Cardiovascular disease in children in Djibouti: a single-centre study. The Pan African Medical Journal, 2013. 14.
Google Scholar
29.↵
Tankeu, A.T., et al., Prevalence and patterns of congenital heart diseases in Africa: a systematic review and meta-analysis protocol. BMJ open, 2017. 7(2): p. e015633.
OpenUrl Abstract/FREE Full Text Google Scholar
30.↵
Choi, S., et al., How do caregivers of children with congenital heart diseases access and navigate the healthcare system in Ethiopia? BMC health services research, 2021. 21: p. 1–7.
OpenUrl CrossRef Google Scholar
31.↵
Tolla, M.T., et al., Out-of-pocket expenditures for prevention and treatment of cardiovascular disease in general and specialised cardiac hospitals in Addis Ababa, Ethiopia: a cross-sectional cohort study. BMJ global health, 2017. 2(2): p. e000280.
Google Scholar
32.↵
Nigussie, B. and H. Tadele, Heart failure in Ethiopian children: mirroring the unmet cardiac services. Ethiopian Journal of Health Sciences, 2019. 29(1).
Google Scholar
33.↵
Araujo Júnior, E., et al., Fetal cardiac evaluation by 3D/4D ultrasonography (STIC): what is its real applicability in the diagnosis of congenital heart disease? 2013, SciELO Brasil. p. III-V.
34.↵
Nobles-Botkin, J., A. Lincoln, and J. Cline, Preconception care resources: Where to start. Journal of Midwifery & Women’s Health, 2016. 61(3): p. 365–369.
OpenUrl Google Scholar
35.↵
Tamirat, M., Congenital heart defects and associated factors in children with congenital anomalies. Ethiopian medical journal, 2018. 56(4): p. 335–341.
OpenUrl Google Scholar
36.
Rocha, L.A., et al., Risk factors for mortality in children with congenital heart disease delivered at a Brazilian tertiary center. Brazilian Journal of Cardiovascular Surgery, 2018. 33: p. 603–607.
OpenUrl Google Scholar
37.
Mat Bah, M.N., et al., Survival and associated risk factors for mortality among infants with critical congenital heart disease in a developing country. Pediatric cardiology, 2018. 39(7): p. 1389–1396.
OpenUrl Google Scholar
38.
Tran, R., et al., Social determinants of disparities in mortality outcomes in congenital heart disease: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 2022. 9: p. 472.
OpenUrl Google Scholar
39.
Best, K.E. and J. Rankin, Long-term survival of individuals born with congenital heart disease: a systematic review and meta-analysis. Journal of the American Heart Association, 2016. 5(6): p. e002846.
OpenUrl Abstract/FREE Full Text Google Scholar
40.
Cheng, H.H., et al., Outcomes and risk factors for mortality in premature neonates with critical congenital heart disease. Pediatric cardiology, 2011. 32: p. 1139–1146.
OpenUrl CrossRef PubMed Google Scholar
41.↵
Polito, A., et al., Increased morbidity and mortality in very preterm/VLBW infants with congenital heart disease. Intensive care medicine, 2013. 39: p. 1104–1112.
OpenUrl Google Scholar
42.↵
Rennie, J.M., Rennie & Roberton’s Textbook of Neonatology E-Book. 2012: Elsevier Health Sciences.
Google Scholar
43.↵
Organization, W.H., Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. 2019.
Google Scholar
44.↵
Organization, W.H., WHO recommendations on antenatal care for a positive pregnancy experience. 2016: World Health Organization.
Google Scholar
45.↵
Hansen, A.R., et al., Cloherty and stark’s manual of neonatal care. 2022: Lippincott Williams & Wilkins.
Google Scholar
46.↵
Targets, W.G.N., 2025: Low birth weight policy brief. World Health Organization, 2014: p. 7.
OpenUrl Google Scholar
47.↵
Kohler, W. and D. Reinger IV, Nelson Textbook of Pediatrics, International Edition, 2-Volume Set. 2019.
Google Scholar
48.↵
Mubayed, L. and S. Al-Kindi, Recent trends in infant mortality due to congenital heart disease in the United States. 2019, American Academy of Pediatrics Elk Grove Village, IL, USA.
Google Scholar
49.↵
Jin, X., et al., Incidence and risk factors of congenital heart disease in Qingdao: a prospective cohort study. BMC Public Health, 2021. 21(1): p. 1044.
OpenUrl Google Scholar
50.↵
Qu, Y., et al., Incidence of congenital heart disease: the 9-year experience of the Guangdong registry of congenital heart disease, China. PloS one, 2016. 11(7): p. e0159257.
OpenUrl PubMed Google Scholar
51.↵
Gamhewage, N., K. Perera, and M. Weerasekera, Effectiveness of newborn pulse oximetry screening for the identification of critical congenital heart disease in a tertiary care hospital in Sri Lanka. Sri Lanka Journal of Child Health, 2021. 50(4): p. 699–703.
OpenUrl Google Scholar
52.↵
Khoshnood, B., et al., Recent decrease in the prevalence of congenital heart defects in Europe. The Journal of pediatrics, 2013. 162(1): p. 108–113. e2.
OpenUrl CrossRef PubMed Web of Science Google Scholar
53.↵
Picarzo, J.P.-L., et al., Congenital heart disease mortality in Spain during a 10 year period (2003–2012). Anales de Pediatría (English Edition), 2018. 88(5): p. 273–279.
OpenUrl Google Scholar
54.↵
Soares, A.M., Mortality for critical congenital heart diseases and associated risk factors in newborns. A cohort study. 2018, SciELO Brasil. p. 674-675.
Google Scholar
55.↵
Tesfaye, E. and H. Tadele, Bacterial Sepsis among Children with Congenital Heart Disease in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiopian Journal of Health Sciences, 2022. 32(3).
Google Scholar
56.
Mekonen, H.K., B. Nigatu, and W.H. Lamers, Birth weight by gestational age and congenital malformations in Northern Ethiopia. BMC pregnancy and childbirth, 2015. 15(1): p. 1–8.
OpenUrl Google Scholar
57.↵
Abebe, S., et al., Risk factors associated with congenital anomalies among newborns in southwestern Ethiopia: A case-control study. PloS one, 2021. 16(1): p. e0245915.
OpenUrl Google Scholar
58.↵
Ascher, S.B., et al., Sepsis in young infants with congenital heart disease. Early human development, 2012. 88: p. S92–S97.
OpenUrl Google Scholar
59.↵
Rosa, R.C.M., et al., Congenital heart defects and extracardiac malformations. Revista Paulista de Pediatria, 2013. 31: p. 243–251.
OpenUrl Google Scholar
60.↵
Van Puyvelde, T., et al., Outcome after cardiopulmonary resuscitation in patients with congenital heart disease. European Heart Journal: Acute Cardiovascular Care, 2018. 7(5): p. 459–466.
OpenUrl Google Scholar

Posted September 25, 2023.

Download PDF

Author Declarations

Data/Code

Citation Tools

Get QR code

Tweet Widget

Subject Area

Obstetrics and Gynecology

Reviews and Context

Comment

TRIP Peer Reviews

Community Reviews

Automated Services

Blogs/Media

Author Videos

Subject Areas

All Articles

Addiction Medicine (423)
Allergy and Immunology (746)
Anesthesia (219)
Cardiovascular Medicine (3240)
Dentistry and Oral Medicine (358)
Dermatology (271)
Emergency Medicine (476)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1153)
Epidemiology (13260)
Forensic Medicine (19)
Gastroenterology (892)
Genetic and Genomic Medicine (5072)
Geriatric Medicine (471)
Health Economics (774)
Health Informatics (3200)
Health Policy (1130)
Health Systems and Quality Improvement (1176)
Hematology (423)
HIV/AIDS (1005)
Infectious Diseases (except HIV/AIDS) (14556)
Intensive Care and Critical Care Medicine (903)
Medical Education (468)
Medical Ethics (126)
Nephrology (515)
Neurology (4829)
Nursing (255)
Nutrition (717)
Obstetrics and Gynecology (871)
Occupational and Environmental Health (783)
Oncology (2490)
Ophthalmology (706)
Orthopedics (279)
Otolaryngology (338)
Pain Medicine (321)
Palliative Medicine (89)
Pathology (533)
Pediatrics (1283)
Pharmacology and Therapeutics (543)
Primary Care Research (551)
Psychiatry and Clinical Psychology (4136)
Public and Global Health (7391)
Radiology and Imaging (1676)
Rehabilitation Medicine and Physical Therapy (994)
Respiratory Medicine (974)
Rheumatology (474)
Sexual and Reproductive Health (492)
Sports Medicine (417)
Surgery (535)
Toxicology (69)
Transplantation (233)
Urology (202)

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

[1] 1.↵
Liu, Y., et al., Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. International journal of epidemiology, 2019. 48(2): p. 455–463.
OpenUrl CrossRef PubMed Google Scholar

[2] 2.↵
Yu, Z., et al., Congenital heart disease in a Chinese hospital: pre-and postnatal detection, incidence, clinical characteristics and outcomes. Pediatrics International, 2011. 53(6): p. 1059–1065.
OpenUrl CrossRef PubMed Google Scholar

[3] 3.↵
Zikarg, Y.T., C.T. Yirdaw, and T.G. Aragie, Prevalence of congenital septal defects among congenital heart defect patients in East Africa: A systematic review and meta-analysis. Plos one, 2021. 16(4): p. e0250006.
OpenUrl Google Scholar

[4] 4.↵
Hurisa, T., H. Megersa, and T. Tsegaye, Delayed in Diagnosis of Congenital Heart Disease and Associated Factors Among Pediatric Patients in Cardiac Center Addis Ababa, Ethiopia, 2021/2022 GC. American Journal of Health Research, 2022. 10(3): p. 51-62.
Google Scholar

[5] 5.↵
Van Der Linde, D., et al., Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. Journal of the American College of Cardiology, 2011. 58(21): p. 2241–2247.
OpenUrl FREE Full Text Google Scholar

[6] 6.↵
Schulkey, C.E., et al., The maternal-age-associated risk of congenital heart disease is modifiable. Nature, 2015. 520(7546): p. 230-233.
Google Scholar

[7] 7.↵
MacColl, C.E., et al., Factors associated with in utero demise of fetuses that have underlying cardiac pathologies. Pediatric cardiology, 2014. 35: p. 1403–1414.
OpenUrl Google Scholar

[8] 8.↵
Leite, D.d.L., H. Miziara, and M. Veloso, Congenital cardiac malformations in pediatric necropsies: characteristics, associations and prevalence. Arquivos Brasileiros de Cardiologia, 2010. 94: p. 294–299.
OpenUrl Google Scholar

[9] 9.↵
Torres-Cosme, J.L., et al., Mortality from congenital heart disease in Mexico: a problem on the rise. PLoS One, 2016. 11(3): p. e0150422.
OpenUrl Google Scholar

[10] 10.↵
Lopes, S.A.V.d.A., et al., Mortality for critical congenital heart diseases and associated risk factors in newborns. A cohort study. Arquivos brasileiros de cardiologia, 2018. 111: p. 666–673.
OpenUrl Google Scholar

[11] 11.↵
Mandalenakis, Z., et al., Survival in children with congenital heart disease: have we reached a peak at 97%? Journal of the American Heart Association, 2020. 9(22): p. e017704.
OpenUrl PubMed Google Scholar

[12] 12.↵
Cucu, I. and M. Chifiriuc, Congenital heart disease: global burden and challenges to eliminate health disparities. Ann Public Health Reports, 2018. 2(1): p. 26–9.
OpenUrl Google Scholar

[13] 13.↵
Musa, N.L., et al., The global burden of paediatric heart disease. Cardiology in the Young, 2017. 27(S6): p. S3–S8.
OpenUrl PubMed Google Scholar

[14] 14.↵
Saxena, A., Status of pediatric cardiac care in developing countries. Children, 2019. 6(2): p. 34.
OpenUrl Google Scholar

[15] 15.↵
Rashid, U., et al., Pattern of congenital heart disease in a developing country tertiary care center: Factors associated with delayed diagnosis. Annals of pediatric cardiology, 2016. 9(3): p. 210.
OpenUrl Google Scholar

[16] 16.↵
Wu, W., J. He, and X. Shao, Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017. Medicine, 2020. 99(23).
Google Scholar

[17] 17.↵
Glidewell, J., et al., Actions in support of newborn screening for critical congenital heart disease—United States, 2011–2018. Morbidity and Mortality Weekly Report, 2019. 68(5): p. 107.
Google Scholar

[18] 18.↵
Su, Z., et al., Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study. EClinicalMedicine, 2022. 43: p. 101249.
Google Scholar

[19] 19.↵
Hewitson, J. and P. Zilla, Children’s heart disease in sub-Saharan Africa: challenging the burden of disease: children’s heart disease. Sa Heart, 2010. 7(1): p. 18–29.
OpenUrl Google Scholar

[20] 20.↵
Vervoort, D., et al., Global cardiac surgery: access to cardiac surgical care around the world. The Journal of thoracic and cardiovascular surgery, 2020. 159(3): p. 987–996. e6.
OpenUrl PubMed Google Scholar

[21] 21.↵
Hoffman, J.I., The global burden of congenital heart disease. Cardiovascular journal of Africa, 2013. 24(4): p. 141–145.
OpenUrl Google Scholar

[22] 22.↵
Zimmerman, M.S., et al., Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Child & Adolescent Health, 2020. 4(3): p. 185-200.
Google Scholar

[23] 23.↵
Jivanji, S.G., et al., Congenital heart disease in East Africa. Frontiers in pediatrics, 2019. 7: p. 250.
OpenUrl Google Scholar

[24] 24.
Howell, H.B., et al., Neurodevelopmental outcomes of children with congenital heart disease: A review. Current Problems in Pediatric and Adolescent Health Care, 2019. 49(10): p. 100685.
OpenUrl CrossRef Google Scholar

[25] 25.↵
Zilla, P., et al., Global unmet needs in cardiac surgery. Global heart, 2018. 13(4): p. 293–303.
OpenUrl Google Scholar

[26] 26.↵
UNICEF, Estimates generated by the UN Inter-agency Group for Child Mortality Estimation (UN IGME). 2014.
Google Scholar

[27] 27.↵
Otaigbe, B. and P. Tabansi, Congenital heart disease in the Niger Delta region of Nigeria: a four-year prospective echocardiographic analysis: cardiovascular topic. Cardiovascular journal of Africa, 2014. 25(6): p. 265–268.
OpenUrl Google Scholar

[28] 28.↵
Massoure, P.-L., et al., Cardiovascular disease in children in Djibouti: a single-centre study. The Pan African Medical Journal, 2013. 14.
Google Scholar

[29] 29.↵
Tankeu, A.T., et al., Prevalence and patterns of congenital heart diseases in Africa: a systematic review and meta-analysis protocol. BMJ open, 2017. 7(2): p. e015633.
OpenUrl Abstract/FREE Full Text Google Scholar

[30] 30.↵
Choi, S., et al., How do caregivers of children with congenital heart diseases access and navigate the healthcare system in Ethiopia? BMC health services research, 2021. 21: p. 1–7.
OpenUrl CrossRef Google Scholar

[31] 31.↵
Tolla, M.T., et al., Out-of-pocket expenditures for prevention and treatment of cardiovascular disease in general and specialised cardiac hospitals in Addis Ababa, Ethiopia: a cross-sectional cohort study. BMJ global health, 2017. 2(2): p. e000280.
Google Scholar

[32] 32.↵
Nigussie, B. and H. Tadele, Heart failure in Ethiopian children: mirroring the unmet cardiac services. Ethiopian Journal of Health Sciences, 2019. 29(1).
Google Scholar

[33] 33.↵
Araujo Júnior, E., et al., Fetal cardiac evaluation by 3D/4D ultrasonography (STIC): what is its real applicability in the diagnosis of congenital heart disease? 2013, SciELO Brasil. p. III-V.

[34] 34.↵
Nobles-Botkin, J., A. Lincoln, and J. Cline, Preconception care resources: Where to start. Journal of Midwifery & Women’s Health, 2016. 61(3): p. 365–369.
OpenUrl Google Scholar

[35] 35.↵
Tamirat, M., Congenital heart defects and associated factors in children with congenital anomalies. Ethiopian medical journal, 2018. 56(4): p. 335–341.
OpenUrl Google Scholar

[36] 36.
Rocha, L.A., et al., Risk factors for mortality in children with congenital heart disease delivered at a Brazilian tertiary center. Brazilian Journal of Cardiovascular Surgery, 2018. 33: p. 603–607.
OpenUrl Google Scholar

[37] 37.
Mat Bah, M.N., et al., Survival and associated risk factors for mortality among infants with critical congenital heart disease in a developing country. Pediatric cardiology, 2018. 39(7): p. 1389–1396.
OpenUrl Google Scholar

[38] 38.
Tran, R., et al., Social determinants of disparities in mortality outcomes in congenital heart disease: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 2022. 9: p. 472.
OpenUrl Google Scholar

[39] 39.
Best, K.E. and J. Rankin, Long-term survival of individuals born with congenital heart disease: a systematic review and meta-analysis. Journal of the American Heart Association, 2016. 5(6): p. e002846.
OpenUrl Abstract/FREE Full Text Google Scholar

[40] 40.
Cheng, H.H., et al., Outcomes and risk factors for mortality in premature neonates with critical congenital heart disease. Pediatric cardiology, 2011. 32: p. 1139–1146.
OpenUrl CrossRef PubMed Google Scholar

[41] 41.↵
Polito, A., et al., Increased morbidity and mortality in very preterm/VLBW infants with congenital heart disease. Intensive care medicine, 2013. 39: p. 1104–1112.
OpenUrl Google Scholar

[42] 42.↵
Rennie, J.M., Rennie & Roberton’s Textbook of Neonatology E-Book. 2012: Elsevier Health Sciences.
Google Scholar

[43] 43.↵
Organization, W.H., Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. 2019.
Google Scholar

[44] 44.↵
Organization, W.H., WHO recommendations on antenatal care for a positive pregnancy experience. 2016: World Health Organization.
Google Scholar

[45] 45.↵
Hansen, A.R., et al., Cloherty and stark’s manual of neonatal care. 2022: Lippincott Williams & Wilkins.
Google Scholar

[46] 46.↵
Targets, W.G.N., 2025: Low birth weight policy brief. World Health Organization, 2014: p. 7.
OpenUrl Google Scholar

[47] 47.↵
Kohler, W. and D. Reinger IV, Nelson Textbook of Pediatrics, International Edition, 2-Volume Set. 2019.
Google Scholar

[48] 48.↵
Mubayed, L. and S. Al-Kindi, Recent trends in infant mortality due to congenital heart disease in the United States. 2019, American Academy of Pediatrics Elk Grove Village, IL, USA.
Google Scholar

[49] 49.↵
Jin, X., et al., Incidence and risk factors of congenital heart disease in Qingdao: a prospective cohort study. BMC Public Health, 2021. 21(1): p. 1044.
OpenUrl Google Scholar

[50] 50.↵
Qu, Y., et al., Incidence of congenital heart disease: the 9-year experience of the Guangdong registry of congenital heart disease, China. PloS one, 2016. 11(7): p. e0159257.
OpenUrl PubMed Google Scholar

[51] 51.↵
Gamhewage, N., K. Perera, and M. Weerasekera, Effectiveness of newborn pulse oximetry screening for the identification of critical congenital heart disease in a tertiary care hospital in Sri Lanka. Sri Lanka Journal of Child Health, 2021. 50(4): p. 699–703.
OpenUrl Google Scholar

[52] 52.↵
Khoshnood, B., et al., Recent decrease in the prevalence of congenital heart defects in Europe. The Journal of pediatrics, 2013. 162(1): p. 108–113. e2.
OpenUrl CrossRef PubMed Web of Science Google Scholar

[53] 53.↵
Picarzo, J.P.-L., et al., Congenital heart disease mortality in Spain during a 10 year period (2003–2012). Anales de Pediatría (English Edition), 2018. 88(5): p. 273–279.
OpenUrl Google Scholar

[54] 54.↵
Soares, A.M., Mortality for critical congenital heart diseases and associated risk factors in newborns. A cohort study. 2018, SciELO Brasil. p. 674-675.
Google Scholar

[55] 55.↵
Tesfaye, E. and H. Tadele, Bacterial Sepsis among Children with Congenital Heart Disease in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiopian Journal of Health Sciences, 2022. 32(3).
Google Scholar

[56] 56.
Mekonen, H.K., B. Nigatu, and W.H. Lamers, Birth weight by gestational age and congenital malformations in Northern Ethiopia. BMC pregnancy and childbirth, 2015. 15(1): p. 1–8.
OpenUrl Google Scholar

[57] 57.↵
Abebe, S., et al., Risk factors associated with congenital anomalies among newborns in southwestern Ethiopia: A case-control study. PloS one, 2021. 16(1): p. e0245915.
OpenUrl Google Scholar

[58] 58.↵
Ascher, S.B., et al., Sepsis in young infants with congenital heart disease. Early human development, 2012. 88: p. S92–S97.
OpenUrl Google Scholar

[59] 59.↵
Rosa, R.C.M., et al., Congenital heart defects and extracardiac malformations. Revista Paulista de Pediatria, 2013. 31: p. 243–251.
OpenUrl Google Scholar

[60] 60.↵
Van Puyvelde, T., et al., Outcome after cardiopulmonary resuscitation in patients with congenital heart disease. European Heart Journal: Acute Cardiovascular Care, 2018. 7(5): p. 459–466.
OpenUrl Google Scholar

Incidence and Predictors of Mortality among Neonates Admitted for Congenital Heart Disease in Public Comprehensives Specialized Hospitals, Amhara Region, Ethiopia 2023

Abstract

Introduction

Method

Study area and period

Study design

Source population

Study population

Eligibility criteria

Inclusion criteria

Exclusion criteria

Sample size determination

Sampling technique and Sampling procedure

Study variables Dependent Variables

Independent variables

Data collection tool and procedure

Operational definitions

Data quality control assurance plan

Data Processing and Analysis

Ethical consideration

Results

Socio-demographic characteristics of mother of neonate

Maternal behavioral factors

Maternal Medical Factors

Maternal obstetrical factors

Neonatal related characteristics

The incidence rate of mortality among congenital heart disease neonates

Overall survival of congenital heart disease neonates admitted to NICU

Survival function among predictor variables

Factor associated with Incidence of neonatal mortality with Admitted to Congenital heart disease

Test of proportional hazard assumption by Schoenfeld’s residuals

Cox-Snell residuals Test

Discussion

Conclusion

Strength and Limitations

Strength

Limitations

Recommendations

Policy Makers and Local leaders

Amhara Regional Health Bureau

Health Professionals and Health Institutions

To future researchers

Data Availability

Supporting information

Authors’ contributions

Acronyms and abbreviation

Acknowledgments

Reference

Subject Area

Follow this preprint